RYAN MACKINNON VASAPOLI AND BERZOK, LLP for GENENTECH
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Monitor drug safety and pedigree legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW BERZOK | — |
| NICK KOLOVOS | — |
| JEFF MACKINNON | — |
| THOMAS RYAN | — |
| JOSEPH V VASAPOLI | — |
Health Issues HCR
Implementation of H.R. 1; Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA, stimulus. Issues relating to comparative effectiveness and CMS converage of FDA approved therapies. Issues related to the PPS rule involving stroke guidelines. Implementation of the follow-on biolotics provisions in P.L. 111-148- "Patient Protection and Affordable Care Act".
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW BERZOK | — |
| NICK KOLOVOS | — |
| JEFF MACKINNON | — |
| THOMAS RYAN | — |
| JOSEPH V VASAPOLI | — |
Medicare/Medicaid MMM
Implementation of H.R. 1; Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA, stimulus. Issues relating to comparative effectiveness and CMS converage of FDA approved therapies. Issues related to the PPS rule involving stroke guidelines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW BERZOK | — |
| NICK KOLOVOS | — |
| JEFF MACKINNON | — |
| THOMAS RYAN | — |
| JOSEPH V VASAPOLI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.